Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis. (Q40593401)
Jump to navigation
Jump to search
scientific article published on January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis. |
scientific article published on January 2004 |
Statements
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis (English)
Iranzu González
Angel Panizo
Susana Inogés
Ana Fontalba
José Luis Fernández-Luna
Mirella Gaboli
Luis Sierrasesúmaga
Salvador Martín-Algarra